Clinical trials

Recherche d’études cliniques

Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.

Réinitialiser

Études cliniques 643

Étude / NCT ⇅ Molécule ⇅ Maladie ⇅ Phase ⇅ Statut ⇅ Résultat ⇅ Sponsor ⇅ Pays / centres ⇅ Période ⇅ Détail
NCT02493049
Pilot Trial of Domperidone in Relapsing-Remitting Multiple Sclerosis (R…
Domperidone SEP Phase 2 COMPLETED En attente / non publié University of Calgary Canada · Calgary MS Clinic at Foothills Medical Centr… 2015-08 → 2019-02 Ouvrir
NCT07189325
DESIRE MS — A Prospective Randomized Non-inferiority Trial Comparing An…
Platform therapies (Dimethyl Fuma… SEP Phase 3 RECRUITING En attente / non publié University Hospital, Montpellier France · Neurology Department, Hospital Gui de Chauli… 2026-06-15 → 2031-06 Ouvrir
NCT03477500
Randomized Autologous heMatopoietic Stem Cell Transplantation Versus Al…
Cyclophosphamide and ATG SEP Phase 3 ACTIVE_NOT_RECRUITING En attente / non publié Haukeland University Hospital Denmark, Netherlands, Norway, Sweden · Akademiska sju… 2018-03-21 → 2028-03-21 Ouvrir
NCT05805839
A Study of Imaging in Demyelinating Diseases
C-11 ER176 Radiotracer SEP Phase 2 ENROLLING_BY_INVITATION En attente / non publié Mayo Clinic United States · Mayo Clinic Minnesota, Rochester, Uni… 2023-07-10 → 2028-05 Ouvrir
NCT02784210
Effect of Corticosteroids on Inflammation at the Edge of Acute Multiple…
Methylprednisolone SEP Phase 2 RECRUITING En attente / non publié Hoffmann-La Roche United States · National Institutes of Health Clinica… 2016-10-05 → 2028-12-31 Ouvrir
NCT07826689
A Phase 1/2a Study of Oral PRO-1562 in Healthy Subjects and Patients Wi…
PRO-1562 Oral Capsules SEP Phase 1/2 NOT_YET_RECRUITING En attente / non publié Progentos Therapeutics Australia · Cmax Clinical Research, Adelaide, Austral… 2026-10 → 2029-02 Ouvrir
NCT07825389
A Study of C-CAR168 in Participants With Progressive Multiple Sclerosis
C-CAR168 SEP Phase 1/2 NOT_YET_RECRUITING En attente / non publié The Affiliated Hospital of Qingda… Non communiqué 2027-02 → 2030-02 Ouvrir
NCT07827586
SONATA-MS — Non-interventional Study of Subcutaneous Ocrelizumab in Per…
Ocrelizumab SEP À vérifier NOT_YET_RECRUITING En attente / non publié Hoffmann-La Roche Non communiqué 2026-09-30 → 2029-05-31 Ouvrir
NCT07827716
A Study to Evaluate the Preliminary Efficacy and Safety of Terfenadine …
Terfenadine SEP Phase 2 RECRUITING En attente / non publié Chuan Qin China · Tongji Hospital, Tongji Medical College, Huaz… 2026-08-15 → 2028-10-30 Ouvrir
NCT07676266
A Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory …
C-CAR168 SEP Phase 1 NOT_YET_RECRUITING En attente / non publié The Affiliated Hospital of Qingda… China · The Affiliated Hospital of Qingdao University… 2026-07 → 2028-10 Ouvrir
NCT04544449
FENtrepid — A Study to Evaluate the Efficacy and Safety of Fenebrutinib…
Fenebrutinib SEP Phase 3 ACTIVE_NOT_RECRUITING En attente / non publié Hoffmann-La Roche United States, Argentina, Australia, Austria, Brazil,… 2020-10-26 → 2027-07-21 Ouvrir
NCT07341828
A Study of C-CAR168 in the Treatment of Central Nervous System Autoimmu…
C-CAR168 SEP Phase 1 NOT_YET_RECRUITING En attente / non publié The Affiliated Hospital of Qingda… Non communiqué 2026-02 → 2029-02 Ouvrir
NCT06249438
CAR-AID — A Study of C-CAR168 in the Treatment of Autoimmune Diseases R…
C-CAR168 SEP Phase 1 RECRUITING En attente / non publié The Affiliated Hospital of Qingda… China · Department of Rheumatology, RenJi Hospital, S… 2024-03-20 → 2040-03 Ouvrir
NCT06595706
Evaluating the Safety and Pharmacokinetics of Multiple Ascending Doses …
Lucid-MS (Lucid-21-302) SEP Phase 1 COMPLETED En attente / non publié Quantum Biopharma Australia · Cmax Clinical Research, Adelaide, Austral… 2024-09-28 → 2025-01-24 Ouvrir
NCT05821387
Evaluating the Safety, Tolerability, Pharmacokinetics, and Effect of Fo…
Lucid-MS (Lucid-21-302) SEP Phase 1 COMPLETED En attente / non publié Quantum Biopharma Canada · Biopharma Services Incorporated, Toronto, Ca… 2023-03-22 → 2023-07-29 Ouvrir
NCT01702025
Rapid Acclimatization to Hypoxia at Altitude
Aminophylline SEP Phase 1/2 COMPLETED En attente / non publié Shanghai Jiao Tong University Aff… United States · Colorado State University, Dept. of H… 2012-06 → 2012-12 Ouvrir
NCT01412827
SPECT-Light — Accuracy of Half of the Usual Radiotracer Dose in SPECT
1/2 dose of 99mTc OR 201Tl tracers SEP Non applicable COMPLETED En attente / non publié Ottawa Heart Institute Research C… Canada · University of Ottawa Heart Institute, Ottawa… 2010-04 → 2014-09 Ouvrir
NCT05666219
Reversal of Complete Heart Block With Aminophylline in Inferior Wall My…
Aminophylline Injection SEP Phase 4 WITHDRAWN En attente / non publié National Institute of Cardiovascu… Non communiqué 2022-12-19 → 2025-01-17 Ouvrir
NCT01655524
ASSUAGE-MPI — The Impact of the Routine Aminophylline Administration Fo…
ASSUAGE Protocol SEP Phase 4 WITHDRAWN En attente / non publié Rush University Medical Center United States · Rush University Medical Center, Chica… 2012-07 → 2014-07 Ouvrir
NCT02983422
Effects of Aminophylline on Renal Function and Urine Volume of AKI Pati…
Aminophylline SEP Phase 1 UNKNOWN En attente / non publié Shanghai Jiao Tong University Aff… Non communiqué 2016-12 → 2017-07 Ouvrir
NCT04240821
Theophylline for Treatment of Pseudohypoparathyroidism
Theophylline ER SEP Phase 2 ENROLLING_BY_INVITATION En attente / non publié Jaclyn Tamaroff United States · Vanderbilt University Medical Center,… 2020-05-22 → 2026-12-31 Ouvrir
NCT01509248
Population Pharmacokinetics and Metabolomics of Theophylline in Preterm…
Population Pharmacokinetics and M… SEP À vérifier UNKNOWN En attente / non publié Seoul National University Hospital Non communiqué 2010-05 Ouvrir
NCT03718403
Effect of Theophylline in Pseudohypoparathyroidism
Theophylline SEP Phase 4 RECRUITING En attente / non publié Hospital Universitari Son Dureta United States · Massachusetts General Hospital, Bosto… 2019-11-11 → 2032-04-10 Ouvrir
NCT01684683
The Effect of Theophylline in the Treatment of Bronchiectasis
Theophylline SEP Phase 4 COMPLETED En attente / non publié Hospital Universitari Son Dureta China · State Key Laboratory of Respiratory Research … 2012-11 → 2014-09 Ouvrir
NCT01263106
A Study of LY2216684 and Theophylline in Healthy Subjects
LY2216684 SEP Phase 1 COMPLETED En attente / non publié Eli Lilly and Company United States · For additional information regarding … 2010-12 → 2011-01 Ouvrir